分组1 - Chemours reported quarterly earnings of 0.32 per share, but down from 1.5 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 5.32% and slightly up from $1.49 billion year-over-year [2] - Chemours has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates two times in the same period [2] 分组2 - The stock has underperformed, losing about 43.5% since the beginning of the year compared to the S&P 500's gain of 20.1% [3] - The current consensus EPS estimate for the coming quarter is 1.35 billion, and for the current fiscal year, it is 5.7 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 20% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]
Chemours (CC) Q3 Earnings and Revenues Top Estimates